Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor

NCT07743554 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

MPNST (Malignant Peripheral Nerve Sheath Tumor)

Interventions

DRUG: avutometinib capsule + defactinib tablet

Sponsor

Girish Dhall, MD

Collaborators

[object Object]
[object Object]
[object Object]